Blog

Nancy Lin: So fitting for a YIA to be dedicated to him and moving to see such an outpouring of support

Photo of Nancy Lin and Felix Feng

May 20, 2024, 14:22

Nancy Lin: So fitting for a YIA to be dedicated to him and moving to see such an outpouring of support

Nancy Lin, Associate Chief of Division of Breast Oncology at Susan F. Smith Center for Women’s Cancers, shared a post by Toni Choueiri, on X/Twitter:

“To my amazing brother-(in law): visionary scientist, incredible mentor, loving husband and father.

He’s lifted up so many.

So fitting for a YIA to be dedicated to him and moving to see such an outpouring of support.

Please donate if you can…”

Quoting Toni Choueiri’s post:

“Announcement of new Felix Feng Endowed ASCO YIA by President-Elect Eric Small.

This is amazing. Huge tribute to the super friend, mentor, far-sighted, generous, leader, trailblazer and kindest!

PLEASE DONATE.”

Nancy Lin: So fitting for a YIA to be dedicated to him and moving to see such an outpouring of support

Source: Nancy Lin/X and Toni Choueiri/X

Toni Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Medical Director of International Strategic Initiatives at Dana-Farber and past President of the Medical Staff at DFCI (2016-2018).

He received the George Canellos Award for Excellence in Clinical Investigation and Patient Care from DFCI in 2013, the Eugene Schonfeld Award from the Kidney Cancer Association (KCA) in 2016, and is a 2021 Giants of Cancer Care inductee. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, KidneyCan Board, the National Cancer Institute (NCI) GU Steering Committee, and is past Chairman (2015-2018) of the Medical and Scientific Steering Committee of the KCA.

Dr. Choueiri is an elected member of the American Society of Clinical Investigation (ASCI). In addition, he is an Aresty Scholar from the Wharton School of Business at the University of Pennsylvania.